Trial Profile
A Phase II Study Comparing Pegylated rhG-CSF(HHPG-19K) and rhG-CSF as Supportive Therapy to Breast Cancer Patients Receiving Neoadjuvant/Adjuvant Chemotherapy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 25 Apr 2014
Price :
$35
*
At a glance
- Drugs Mecapegfilgrastim (Primary) ; Filgrastim
- Indications Neutropenia
- Focus Therapeutic Use
- Sponsors Jiangsu Hengrui Medicine Co.
- 25 Apr 2014 New trial record